Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 5 | Cellular & Molecular Biology Letters

Fig. 5

From: Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival

Fig. 5

Association of CDKN2B-AS1 gene expression level with clinical and pathological parameters. a Side of the BC. b Number of BC masses. c BC grade. d BC tumor size. e Lymph node stage. f Distant metastasis. g Lymphovascular infiltration. h Clinical stage of BC patients. i Nottingham prognostic index for BC patients. j Recurrence of BC patients. Fold change was log10 transformed. Student’s t-test was used. P-values below 0.05 were set to be significant. OQ outer quadrant, LN lymph node, LVI lymphovascular infiltration, NPI Nottingham prognostic index

Back to article page